Scientists found a tiny ocean organism doing big things. This isn't just any bacteria—it's a type of cyanobacterium called Capilliphycus salinus ALCB114379. It lives where the ocean meets land in Brazil, where tides and weather constantly change. This tough little survivor has a complete genome mapp
Eascra Biotech, a startup that builds tiny delivery machines for medicines, has hired Dr. Anne Yau as a Life Science Research Scientist. She will work in the company’s preclinical laboratory at the Massachusetts Biomedical Initiatives facility in Worcester, where researchers test new tools before
Pharmaceutical giant Eli Lilly just dropped $3. 25 billion upfront on a startup called Kelonia Therapeutics, with the potential to pay $7 billion total if everything goes right. The big idea? A treatment that turns your own immune cells into cancer fighters without the usual lab work. Instead of yan
San Diego’s science labs are mostly empty. About a third of the space sits unused, which is almost as high as it has ever been. The city’s rental rates are dropping and landlords offer more discounts, so some companies are stepping in. The latest data shows a split scene. Venture money is coming ba
OpenAI’s newest AI model, named after DNA pioneer Rosalind Franklin, isn’t built to write poems or plan dinner menus. Instead, it’s trained to dig through mountains of scientific data to help researchers find new medicines faster. Drug development usually takes over a decade, but this tool could cut
CareDx just decided to sell off one of its smaller businesses so it can double down on the parts that are actually making money. The company’s president once said the division being sold—Lab Products, which makes test kits used worldwide—operates differently from the rest of their business. That’s b
Science Corp isn't diving into brain surgery just for the thrill. The company plans to place a tiny sensor on a human brain during an already scheduled operation. The 520-electrode chip, no bigger than a pea, will rest on the brain's surface, recording activity without digging deep. This isn't a sci
Two biotech firms are trying to cash in on investor excitement around obesity drugs and disease-detecting technology. One company wants $533 million to develop weight-loss treatments, while another seeks $159 million to expand its diagnostic tools. Both plan to sell shares to the public soon, hoping
A Chinese biotech company in Suzhou has given an American firm the worldwide rights to create and sell six new RNA medicines aimed at a serious liver condition. The deal brings an upfront cash payment of $60 million and could grow to nearly $4. 5 billion if the medicines reach several key develop
Scientists have been working on making a special enzyme better at producing a form of vitamin D. This enzyme is a mix of different parts, like a custom-made tool. The usual way to improve such enzymes is to tweak small parts here and there. But this time, the team took a bigger picture approach. Th
